Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

QLT INC T.QLT

Healthcare Biotechnology
"QLT Inc is a biotechnology company conducts development and commercialization of ocular products that address the unmet medical needs of patients and clinicians."


TSX:QLT - Post by User

QLT INC > $167 US in cash
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by TheRock07on Feb 10, 2015 4:43pm
107 Views
Post# 23415757

RE:RE:$167 US in cash

RE:RE:$167 US in cash Nice to see someone else post here.
Their drug should be worth $50 million but the real upside will be in the deal..
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities